Eduardo Cronemberger

1.5k total citations
15 papers, 94 citations indexed

About

Eduardo Cronemberger is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Eduardo Cronemberger has authored 15 papers receiving a total of 94 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Surgery. Recurrent topics in Eduardo Cronemberger's work include Lung Cancer Treatments and Mutations (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Eduardo Cronemberger is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Eduardo Cronemberger collaborates with scholars based in Brazil, United States and South Korea. Eduardo Cronemberger's co-authors include Mauro Zukin, Mauro Zamboni, Clarissa Baldotto, I. A. Small, Renata D’Alpino Peixoto, Carlos Gil Ferreira, Paulo Guilherme de Oliveira Salles, Beverly Moy, William J. Gradishar and Simon Waters and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Eduardo Cronemberger

14 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Cronemberger Brazil 7 61 48 18 17 14 15 94
Alice Baggi Italy 6 64 1.0× 66 1.4× 11 0.6× 23 1.4× 9 0.6× 13 109
Sanjeev Sewak Australia 5 54 0.9× 44 0.9× 7 0.4× 7 0.4× 22 1.6× 11 90
Mathieu Baconnier France 6 45 0.7× 106 2.2× 20 1.1× 12 0.7× 9 0.6× 15 130
Sherif Raouf United Kingdom 8 46 0.8× 82 1.7× 13 0.7× 10 0.6× 21 1.5× 13 111
Tatiana Hadjieva Bulgaria 5 61 1.0× 47 1.0× 18 1.0× 6 0.4× 26 1.9× 7 154
Chu Van Nguyen Vietnam 7 37 0.6× 62 1.3× 26 1.4× 10 0.6× 11 0.8× 36 114
Christin A. Knowlton United States 6 55 0.9× 24 0.5× 31 1.7× 6 0.4× 24 1.7× 12 100
Laura Mazzeo Italy 7 25 0.4× 60 1.3× 11 0.6× 18 1.1× 12 0.9× 19 111
Alisha Moore Australia 6 39 0.6× 31 0.6× 7 0.4× 14 0.8× 11 0.8× 17 84
Jaseela Chiramel United Kingdom 4 28 0.5× 55 1.1× 11 0.6× 23 1.4× 7 0.5× 6 76

Countries citing papers authored by Eduardo Cronemberger

Since Specialization
Citations

This map shows the geographic impact of Eduardo Cronemberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Cronemberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Cronemberger more than expected).

Fields of papers citing papers by Eduardo Cronemberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Cronemberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Cronemberger. The network helps show where Eduardo Cronemberger may publish in the future.

Co-authorship network of co-authors of Eduardo Cronemberger

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Cronemberger. A scholar is included among the top collaborators of Eduardo Cronemberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Cronemberger. Eduardo Cronemberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Werutsky, Gustavo, Juliana Giacomazzi, Daniela Dornelles Rosa, et al.. (2024). The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation. Revista Brasileira Ginecologia e Obstetrícia. 46.
2.
Ramalingam, Suresh S., Terufumi Kato, Xiaorong Dong, et al.. (2024). Osimertinib (osi) after definitive chemoradiotherapy (CRT) in patients (pts) with unresectable stage (stg) III epidermal growth factor receptor-mutated (EGFRm) NSCLC: Primary results of the phase 3 LAURA study.. Journal of Clinical Oncology. 42(17_suppl). LBA4–LBA4. 5 indexed citations
3.
Maluf, Fernando Cotait, Andrey Soares, Diogo Assed Bastos, et al.. (2022). Survival analysis of the randomized phase II trial to investigate androgen signaling inhibitors with or without androgen deprivation therapy (ADT) for castration-sensitive prostate cancer: LACOG 0415.. Journal of Clinical Oncology. 40(16_suppl). 5076–5076. 1 indexed citations
4.
Saura, Cristina, Judit Matito, Mafalda Oliveira, et al.. (2021). Biomarker Analysis of the Phase III NALA Study of Neratinib + Capecitabine versus Lapatinib + Capecitabine in Patients with Previously Treated Metastatic Breast Cancer. Clinical Cancer Research. 27(21). 5818–5827. 15 indexed citations
5.
Rosa, Daniela Dornelles, José Bines, Gustavo Werutsky, et al.. (2021). Sociodemographic and clinicopathologic features of elderly breast cancer patients in Brazil: A sub-analysis of AMAZONA III study (GBCAM 0115).. Journal of Clinical Oncology. 39(15_suppl). e12603–e12603. 2 indexed citations
6.
Cronemberger, Eduardo, Clarissa Baldotto, Pedro De Marchi, et al.. (2020). Real-World Molecular Testing and Treatment Patterns in Brazilian Patients with Newly Diagnosed Locally Advanced or Metastatic NSCLC. Clinics. 75. e1777–e1777. 6 indexed citations
7.
Peixoto, Renata D’Alpino, et al.. (2020). Resected High-Risk Rectal GIST Harboring NTRK1 Fusion: a Case Report and Review of the Literature. Journal of Gastrointestinal Cancer. 52(1). 316–319. 9 indexed citations
8.
Maluf, Fernando Cotait, André P. Fay, Fabio A. Schutz, et al.. (2020). Phase II randomized study of abiraterone acetate plus prednisone (AAP) added to ADT versus apalutamide alone (APA) versus AAP+APA in patients with advanced prostate cancer with noncastrate testosterone levels: (LACOG 0415).. Journal of Clinical Oncology. 38(15_suppl). 5505–5505. 3 indexed citations
10.
Cronemberger, Eduardo, et al.. (2019). Molecular profile of non-small cell lung cancer in northeastern Brazil. Jornal Brasileiro de Pneumologia. 45(3). e20180181–e20180181. 11 indexed citations
11.
12.
Cronemberger, Eduardo, Clarissa Baldotto, Pedro De Marchi, et al.. (2018). P3.01-12 EGFR Mutation and Targeted Therapies: Difficulties and Disparities in Access to NSCLC Treatment in Brazil. Journal of Thoracic Oncology. 13(10). S871–S872. 1 indexed citations
13.
Baldotto, Clarissa, Eduardo Cronemberger, Pedro De Marchi, et al.. (2018). P23 Stage IIIb NSCLC and Curative Intention Treatment: Difficulties and Disparities in Brazil. Journal of Thoracic Oncology. 13(9). S169–S170. 1 indexed citations
14.
Melo, Andréia Cristina de, Aknar Calabrich, Eduardo Cronemberger, et al.. (2018). Social disparities and patients’ attitudes are associated with lower rates of cervical cancer screening in Brazil: Results of EVITA study (LACOG 0215).. Journal of Clinical Oncology. 36(15_suppl). e17510–e17510. 1 indexed citations
15.
Baldotto, Clarissa, Eduardo Cronemberger, Mauro Zamboni, et al.. (2012). Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?. Supportive Care in Cancer. 20(11). 2721–2727. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026